1. Home
  2. CABA vs BNED Comparison

CABA vs BNED Comparison

Compare CABA & BNED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$2.77

Market Cap

495.7M

Sector

Health Care

ML Signal

HOLD

Logo Barnes & Noble Education Inc

BNED

Barnes & Noble Education Inc

HOLD

Current Price

$12.53

Market Cap

399.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CABA
BNED
Founded
2017
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
495.7M
399.5M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
CABA
BNED
Price
$2.77
$12.53
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$14.50
N/A
AVG Volume (30 Days)
3.5M
324.1K
Earning Date
05-14-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
10.26
119.60
EPS
N/A
0.49
Revenue
N/A
$1,714,770,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$25.88
Revenue Growth
N/A
6.50
52 Week Low
$1.26
$5.90
52 Week High
$4.23
$14.75

Technical Indicators

Market Signals
Indicator
CABA
BNED
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
CABA
BNED

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is a contract operator of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States. The company is also a textbook wholesaler and inventory management hardware and software provider. It offers course materials through physical and online bookstores, including new and used print textbooks, rental options, digital textbooks, and publisher-hosted digital courseware. Products are also offered directly to students through Textbooks.com. The majority of the company's revenue is derived from the sale of products through its bookstore locations, including virtual bookstores, and the bookstore affiliated e-commerce websites.

Share on Social Networks: